Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition

Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.BACKGROUNDBreast cancer is a heterogenous disease composed of multiple clonal populations and the mechanis...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1866; no. 11; p. 130215
Main Authors Kundu, Priya, Shankar, Bhavani S.
Format Journal Article
LanguageEnglish
Published 01.11.2022
Subjects
Online AccessGet full text
ISSN0304-4165
1872-8006
1872-8006
DOI10.1016/j.bbagen.2022.130215

Cover

Abstract Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.BACKGROUNDBreast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.MCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.METHODSMCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.MɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.RESULTSMɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.ERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.CONCLUSIONSERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.Our experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.GENERAL SIGNIFICANCEOur experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.
AbstractList Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood. MCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments. MɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1⁺) and mesenchymal (CD44⁺ CD24⁻ cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance. ERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals. Our experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.
Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.BACKGROUNDBreast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.MCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.METHODSMCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.MɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.RESULTSMɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.ERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.CONCLUSIONSERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.Our experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.GENERAL SIGNIFICANCEOur experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.
ArticleNumber 130215
Author Kundu, Priya
Shankar, Bhavani S.
Author_xml – sequence: 1
  givenname: Priya
  surname: Kundu
  fullname: Kundu, Priya
– sequence: 2
  givenname: Bhavani S.
  surname: Shankar
  fullname: Shankar, Bhavani S.
BookMark eNqFkUGOFCEUhokZE3vGuYELlm6qBaqAKnemMz0aZzLJZGZNgHrVTYeiSqBN-izewoN4JilbNy6UhPAI3__g579EF2EKgNAbStaUUPHusDZG7yCsGWFsTWvCKH-BVrSVrGoJERdoRWrSVA0V_BW6TOlAyuAdX6Fv99rGad4XOXahP1ro8c3j5-rpdlv9-E5xcrugvQu7corvN1uJTQSdMrY6WIjYgvcJR0hHnxckwleIyRkPf4iUYfyF4dkXobMun7AOPYbZ5T14pz0eIUGw-9NY6hx1SC67KbxGLwftE1z_Xq_Q8_bmafOxunu4_bT5cFdZ1shc2dZQOwhjiO2EFLzsRCcYL5OxprdSMt6YjnV9w6kw7UB0O1CQlAy16HVdX6G3575znL4cIWU1urS8WAeYjkkxSdu66Urr_6Pl5pZ3su0K-v6Mlv9NKcKginO9-CoOnVeUqCU8dVDn8NQSnjqHV8TNX-I5ulHH079lPwFwM6Rk
CitedBy_id crossref_primary_10_1002_jcp_31278
crossref_primary_10_1016_j_jtos_2024_08_014
crossref_primary_10_1038_s41392_024_01851_y
crossref_primary_10_31083_j_fbl2809230
crossref_primary_10_3389_fcell_2023_1221175
crossref_primary_10_47248_chp2502010004
Cites_doi 10.1002/path.2793
10.1007/s12079-019-00508-8
10.3892/or.2017.5955
10.1016/j.stemcr.2015.12.006
10.1053/j.gastro.2014.08.039
10.1016/j.biopha.2018.12.055
10.3390/cancers12123765
10.1038/onc.2015.133
10.1038/s41598-019-57285-y
10.1002/cbin.11525
10.1158/0008-5472.CAN-10-2638
10.1073/pnas.1102454108
10.1016/j.cellsig.2014.03.028
10.1038/s41598-018-27021-z
10.1038/onc.2010.546
10.1158/0008-5472.CAN-18-3962
10.1155/2019/7683817
10.1073/pnas.1815345116
10.1165/rcmb.2004-0288OC
10.1155/2019/3904645
10.1016/j.molonc.2015.10.002
10.1016/j.stemcr.2018.03.001
10.1158/2159-8290.CD-19-0015
10.1073/pnas.1812876116
10.1088/1478-3975/ab34df
10.1016/j.canlet.2014.05.008
10.18632/oncotarget.24917
10.1007/s10585-021-10139-2
10.18632/oncotarget.21068
10.1038/srep24606
10.1038/ncomms2039
10.1038/s41598-017-14364-2
10.3390/ijms20112767
10.1016/j.bpj.2013.07.011
10.18632/oncotarget.16624
10.1101/cshperspect.a022301
10.1158/1940-6207.CAPR-10-0234
10.1073/pnas.1018898108
10.1126/scisignal.aau8544
10.1586/erm.12.117
10.1038/srep29479
10.1126/science.959840
10.1186/s10020-021-00383-3
10.1155/2016/1740936
10.1593/neo.04241
ContentType Journal Article
Copyright Copyright © 2022 Elsevier B.V. All rights reserved.
Copyright_xml – notice: Copyright © 2022 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2022.130215
DatabaseName CrossRef
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
ExternalDocumentID 10_1016_j_bbagen_2022_130215
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
AAYXX
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABWVN
ABXDB
ACDAQ
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AEUPX
AFJKZ
AFPUW
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGRNS
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CITATION
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
7X8
EFKBS
EFLBG
7S9
L.6
ID FETCH-LOGICAL-c247t-c8b1cf6bb0c96765b1c69625962224dc77254b929d4516b8f0a8f1e710f36da33
ISSN 0304-4165
1872-8006
IngestDate Thu Sep 04 17:14:37 EDT 2025
Fri Sep 05 09:52:38 EDT 2025
Tue Jul 01 00:22:17 EDT 2025
Thu Apr 24 23:06:36 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c247t-c8b1cf6bb0c96765b1c69625962224dc77254b929d4516b8f0a8f1e710f36da33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2696859789
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2718349765
proquest_miscellaneous_2696859789
crossref_citationtrail_10_1016_j_bbagen_2022_130215
crossref_primary_10_1016_j_bbagen_2022_130215
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-00
20221101
PublicationDateYYYYMMDD 2022-11-01
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-00
PublicationDecade 2020
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationYear 2022
References Wan (10.1016/j.bbagen.2022.130215_bb0165) 2014; 147
Iliopoulos (10.1016/j.bbagen.2022.130215_bb0160) 2011; 108
Bruna (10.1016/j.bbagen.2022.130215_bb0170) 2012; 3
Jia (10.1016/j.bbagen.2022.130215_bb0205) 2019; 16
Xie (10.1016/j.bbagen.2022.130215_bb0080) 2004; 6
Chen (10.1016/j.bbagen.2022.130215_bb0235) 2016; 2016
Hojo (10.1016/j.bbagen.2022.130215_bb0045) 2018; 8
Bednarczyk (10.1016/j.bbagen.2022.130215_bb0095) 2018; 9
Colacino (10.1016/j.bbagen.2022.130215_bb0115) 2018; 10
Michor (10.1016/j.bbagen.2022.130215_bb0225) 2010; 3
Vassalli (10.1016/j.bbagen.2022.130215_bb0070) 2019; 2019
Chiou (10.1016/j.bbagen.2022.130215_bb0055) 2010; 70
Chaffer (10.1016/j.bbagen.2022.130215_bb0005) 2011; 108
Hao (10.1016/j.bbagen.2022.130215_bb0145) 2019; 20
Yadav (10.1016/j.bbagen.2022.130215_bb0075) 2021; 45
Hinshaw (10.1016/j.bbagen.2022.130215_bb0010) 2019; 79
Singh (10.1016/j.bbagen.2022.130215_bb0015) 1862; 2018
Li (10.1016/j.bbagen.2022.130215_bb0105) 2017; 7
Zhang (10.1016/j.bbagen.2022.130215_bb0065) 2020; 12
Saadin (10.1016/j.bbagen.2022.130215_bb0135) 2013; 13
Katsuno (10.1016/j.bbagen.2022.130215_bb0185) 2019; 12
Singh (10.1016/j.bbagen.2022.130215_bb0035) 2014; 26
Allavena (10.1016/j.bbagen.2022.130215_bb0100) 2021; 27
Wang (10.1016/j.bbagen.2022.130215_bb0050) 2016; 6
Ruiz (10.1016/j.bbagen.2022.130215_bb0130) 2019; 2019
Yuan (10.1016/j.bbagen.2022.130215_bb0085) 2019; 9
Stylianou (10.1016/j.bbagen.2022.130215_bb0020) 1862; 2018
Andriani (10.1016/j.bbagen.2022.130215_bb0230) 2016; 10
Bocci (10.1016/j.bbagen.2022.130215_bb0110) 2019; 116
Sullivan (10.1016/j.bbagen.2022.130215_bb0195) 2005; 32
Akhurst (10.1016/j.bbagen.2022.130215_bb0240) 2017; 9
Alison (10.1016/j.bbagen.2022.130215_bb0040) 2011; 223
Liang (10.1016/j.bbagen.2022.130215_bb0180) 2016; 6
Kröger (10.1016/j.bbagen.2022.130215_bb0120) 2019; 116
Ehata (10.1016/j.bbagen.2022.130215_bb0175) 2011; 30
Zhang (10.1016/j.bbagen.2022.130215_bb0025) 2017; 8
Fan (10.1016/j.bbagen.2022.130215_bb0030) 2014; 352
Li (10.1016/j.bbagen.2022.130215_bb0190) 2020; 10
Tian (10.1016/j.bbagen.2022.130215_bb0200) 2013; 105
Yadav (10.1016/j.bbagen.2022.130215_bb0060) 2019; 111
Akrap (10.1016/j.bbagen.2022.130215_bb0140) 2016; 6
Sahoo (10.1016/j.bbagen.2022.130215_bb0125) 2022; 39
Gao (10.1016/j.bbagen.2022.130215_bb0090) 2018; 40
Pang (10.1016/j.bbagen.2022.130215_bb0150) 2016; 35
Nowell (10.1016/j.bbagen.2022.130215_bb0220) 1976; 194
Liao (10.1016/j.bbagen.2022.130215_bb0155) 2019; 13
Li (10.1016/j.bbagen.2022.130215_bb0210) 2017; 8
Zhao (10.1016/j.bbagen.2022.130215_bb0215) 2017; 38
References_xml – volume: 223
  start-page: 147
  year: 2011
  ident: 10.1016/j.bbagen.2022.130215_bb0040
  article-title: Cancer stem cells: problems for therapy?
  publication-title: J. Pathol.
  doi: 10.1002/path.2793
– volume: 13
  start-page: 369
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0155
  article-title: TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation
  publication-title: J. Cell Commun. Signal.
  doi: 10.1007/s12079-019-00508-8
– volume: 38
  start-page: 3055
  year: 2017
  ident: 10.1016/j.bbagen.2022.130215_bb0215
  article-title: MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing β-catenin nuclear accumulation
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2017.5955
– volume: 2018
  start-page: 669
  year: 1862
  ident: 10.1016/j.bbagen.2022.130215_bb0015
  article-title: Significant alterations of the novel 15 gene signature identified from macrophage-tumor interactions in breast cancer
  publication-title: Biochim. Biophys. Acta Gen. Subj.
– volume: 6
  start-page: 121
  year: 2016
  ident: 10.1016/j.bbagen.2022.130215_bb0140
  article-title: Identification of distinct breast cancer stem cell populations based on single-cell analyses of functionally enriched stem and progenitor pools
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2015.12.006
– volume: 147
  start-page: 1393
  year: 2014
  ident: 10.1016/j.bbagen.2022.130215_bb0165
  article-title: Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2014.08.039
– volume: 111
  start-page: 119
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0060
  article-title: Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2018.12.055
– volume: 12
  year: 2020
  ident: 10.1016/j.bbagen.2022.130215_bb0065
  article-title: Breast cancer stem cells: biomarkers, identification and isolation methods, regulating mechanisms, cellular origin, and beyond
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12123765
– volume: 35
  start-page: 748
  year: 2016
  ident: 10.1016/j.bbagen.2022.130215_bb0150
  article-title: TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
  publication-title: Oncogene
  doi: 10.1038/onc.2015.133
– volume: 10
  start-page: 377
  year: 2020
  ident: 10.1016/j.bbagen.2022.130215_bb0190
  article-title: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-57285-y
– volume: 45
  start-page: 804
  year: 2021
  ident: 10.1016/j.bbagen.2022.130215_bb0075
  article-title: Proteomic analysis of radio-resistant breast cancer xenografts: increased TGF-β signaling and metabolism
  publication-title: Cell Biol. Int.
  doi: 10.1002/cbin.11525
– volume: 70
  start-page: 10433
  year: 2010
  ident: 10.1016/j.bbagen.2022.130215_bb0055
  article-title: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-2638
– volume: 108
  start-page: 7950
  year: 2011
  ident: 10.1016/j.bbagen.2022.130215_bb0005
  article-title: Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1102454108
– volume: 26
  start-page: 1604
  year: 2014
  ident: 10.1016/j.bbagen.2022.130215_bb0035
  article-title: TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2014.03.028
– volume: 8
  start-page: 8704
  year: 2018
  ident: 10.1016/j.bbagen.2022.130215_bb0045
  article-title: Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-27021-z
– volume: 30
  start-page: 1693
  year: 2011
  ident: 10.1016/j.bbagen.2022.130215_bb0175
  article-title: Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells
  publication-title: Oncogene
  doi: 10.1038/onc.2010.546
– volume: 79
  start-page: 4557
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0010
  article-title: The tumor microenvironment innately modulates cancer progression
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-3962
– volume: 2019
  start-page: 7683817
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0130
  article-title: Genes involved in the transcriptional regulation of pluripotency are expressed in malignant tumors of the uterine cervix and can induce tumorigenic capacity in a nontumorigenic cell line
  publication-title: Stem Cells Int.
  doi: 10.1155/2019/7683817
– volume: 116
  start-page: 148
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0110
  article-title: Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.1815345116
– volume: 32
  start-page: 342
  year: 2005
  ident: 10.1016/j.bbagen.2022.130215_bb0195
  article-title: Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.2004-0288OC
– volume: 2019
  start-page: 3904645
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0070
  article-title: Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells
  publication-title: Stem Cells Int.
  doi: 10.1155/2019/3904645
– volume: 2018
  start-page: 1537
  year: 1862
  ident: 10.1016/j.bbagen.2022.130215_bb0020
  article-title: Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion
  publication-title: Biochim. Biophys. Acta Gen. Subj.
– volume: 10
  start-page: 253
  year: 2016
  ident: 10.1016/j.bbagen.2022.130215_bb0230
  article-title: Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells
  publication-title: Mol. Oncol.
  doi: 10.1016/j.molonc.2015.10.002
– volume: 10
  start-page: 1596
  year: 2018
  ident: 10.1016/j.bbagen.2022.130215_bb0115
  article-title: Heterogeneity of human breast stem and progenitor cells as revealed by transcriptional profiling
  publication-title: Stem Cell Reports
  doi: 10.1016/j.stemcr.2018.03.001
– volume: 9
  start-page: 837
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0085
  article-title: Cellular plasticity in cancer
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-19-0015
– volume: 116
  start-page: 7353
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0120
  article-title: Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1812876116
– volume: 16
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0205
  article-title: A possible role for epigenetic feedback regulation in the dynamics of the epithelial-mesenchymal transition (EMT)
  publication-title: Phys. Biol.
  doi: 10.1088/1478-3975/ab34df
– volume: 352
  start-page: 160
  year: 2014
  ident: 10.1016/j.bbagen.2022.130215_bb0030
  article-title: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2014.05.008
– volume: 9
  start-page: 24272
  year: 2018
  ident: 10.1016/j.bbagen.2022.130215_bb0095
  article-title: Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24917
– volume: 39
  start-page: 279
  year: 2022
  ident: 10.1016/j.bbagen.2022.130215_bb0125
  article-title: Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer
  publication-title: Clin. Exp. Metastasis
  doi: 10.1007/s10585-021-10139-2
– volume: 8
  start-page: 99801
  year: 2017
  ident: 10.1016/j.bbagen.2022.130215_bb0025
  article-title: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.21068
– volume: 6
  start-page: 24606
  year: 2016
  ident: 10.1016/j.bbagen.2022.130215_bb0050
  article-title: Twist-mediated epithelial-mesenchymal transition promotes breast tumor cell invasion via inhibition of hippo pathway
  publication-title: Sci. Rep.
  doi: 10.1038/srep24606
– volume: 3
  start-page: 1055
  year: 2012
  ident: 10.1016/j.bbagen.2022.130215_bb0170
  article-title: TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms2039
– volume: 7
  start-page: 13856
  year: 2017
  ident: 10.1016/j.bbagen.2022.130215_bb0105
  article-title: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-14364-2
– volume: 20
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0145
  article-title: TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20112767
– volume: 105
  start-page: 1079
  year: 2013
  ident: 10.1016/j.bbagen.2022.130215_bb0200
  article-title: Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition
  publication-title: Biophys. J.
  doi: 10.1016/j.bpj.2013.07.011
– volume: 8
  start-page: 33694
  year: 2017
  ident: 10.1016/j.bbagen.2022.130215_bb0210
  article-title: AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.16624
– volume: 9
  year: 2017
  ident: 10.1016/j.bbagen.2022.130215_bb0240
  article-title: Targeting TGF-β signaling for therapeutic gain
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a022301
– volume: 40
  start-page: 2558
  year: 2018
  ident: 10.1016/j.bbagen.2022.130215_bb0090
  article-title: Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma
  publication-title: Oncol. Rep.
– volume: 3
  start-page: 1361
  year: 2010
  ident: 10.1016/j.bbagen.2022.130215_bb0225
  article-title: The origins and implications of intratumor heterogeneity
  publication-title: Cancer Prev. Res. (Phila.)
  doi: 10.1158/1940-6207.CAPR-10-0234
– volume: 108
  start-page: 1397
  year: 2011
  ident: 10.1016/j.bbagen.2022.130215_bb0160
  article-title: Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1018898108
– volume: 12
  year: 2019
  ident: 10.1016/j.bbagen.2022.130215_bb0185
  article-title: Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.aau8544
– volume: 13
  start-page: 49
  year: 2013
  ident: 10.1016/j.bbagen.2022.130215_bb0135
  article-title: Breast cancer stem cell enrichment and isolation by mammosphere culture and its potential diagnostic applications
  publication-title: Expert. Rev. Mol. Diagn.
  doi: 10.1586/erm.12.117
– volume: 6
  start-page: 29479
  year: 2016
  ident: 10.1016/j.bbagen.2022.130215_bb0180
  article-title: Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model
  publication-title: Sci. Rep.
  doi: 10.1038/srep29479
– volume: 194
  start-page: 23
  year: 1976
  ident: 10.1016/j.bbagen.2022.130215_bb0220
  article-title: The clonal evolution of tumor cell populations
  publication-title: Science
  doi: 10.1126/science.959840
– volume: 27
  start-page: 121
  year: 2021
  ident: 10.1016/j.bbagen.2022.130215_bb0100
  article-title: Macrophages and cancer stem cells: a malevolent alliance
  publication-title: Mol. Med.
  doi: 10.1186/s10020-021-00383-3
– volume: 2016
  start-page: 1740936
  year: 2016
  ident: 10.1016/j.bbagen.2022.130215_bb0235
  article-title: Cancer stem cell quiescence and plasticity as major challenges in cancer therapy
  publication-title: Stem Cells Int.
  doi: 10.1155/2016/1740936
– volume: 6
  start-page: 603
  year: 2004
  ident: 10.1016/j.bbagen.2022.130215_bb0080
  article-title: Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
  publication-title: Neoplasia
  doi: 10.1593/neo.04241
SSID ssj0000595
Score 2.4247003
Snippet Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell...
SourceID proquest
crossref
SourceType Aggregation Database
Enrichment Source
Index Database
StartPage 130215
SubjectTerms breast neoplasms
epithelium
hybrids
interleukin-6
macrophages
neutralization
phosphorylation
plasticity
stem cells
vimentin
Title Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition
URI https://www.proquest.com/docview/2696859789
https://www.proquest.com/docview/2718349765
Volume 1866
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF6FIgQXBAXUUkCLRE-WI6__c6RRQgVNkcCRcrN2N7bsEpwqsQ_pgXfgzFvwIDwTM7v-SdQKChcn2UycxPN5d2b2mxlC3jAmwYpnnhlyaZkuE8wUfpqagg_gQTi2Z2Ny8uTcP52672ferNf7vsVaqkrRl1c35pX8j1ZhDPSKWbL_oNn2pDAAz0G_cAQNw_FWOp5wbMCVIe0GXOsKt_JHnz6Y0buxeTwcHZ_YzEB-Bl_UiSuT4TgwBNLQS2R7yWRlYOAedw7W1aLUuS2Kp4H5VLUEVnpWYthxGqs6o92O4fbkEvM5FrnKP1nDdck2XxV1HVa_vNV3s2GcL2WWY20CIykNkS91SIVjMQ_eb6pfG-tKYGBoa4cJ_peydFf5pl1BPme8-KKZ4ScZB18gryO4dfgCPF_Whi_0jBsGMCVbVl0P-4axdprW7VkaQLKtaRd3X3VW6LUVQQcnLvpCgCAWvLXtfie-W4D7_GM8np6dxdFoFt0hd-0gUDv__W8dawisUWTFtr-wycZUlMHr37Fr7ewu9sqCiR6Rh7XrQd9qHD0mvaTYJ_d0M9LNPrk_bHr_PSE_OmTRGlm0Qdavn4y2qIJ3KaKKalRRjRmqUEU1qlCkQ1UjgahSYrRDFQVU0Q5VdAtVtEPVUzIdj6LhqVm38TCl7QalKUPBZOoLYcmBH_gevPIH6Hb7YJu6cwn-necKMNPn2DRahKnFw5QlYPqmjj_njvOM7BXLIjkgNOVgvgrwSBjHGrjz0LUt7qeJK8MgtaR_SJzmcseyrnGPrVYWcUNmvIi1kmJUUqyVdEjM9lOXusbLX-RfN5qMQS94rXiRLKt1bGOpKXDRw8EfZMAadFzwArzntzjPEXnQ3TUvyF65qpKXYAaX4pUC5m9O8bfn
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Macrophage+induced+ERK-TGF-%CE%B21+signaling+in+MCF7+breast+cancer+cells+result+in+reversible+cancer+stem+cell+plasticity+and+epithelial+mesenchymal+transition&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Kundu%2C+Priya&rft.au=Shankar%2C+Bhavani+S&rft.date=2022-11-01&rft.issn=1872-8006&rft.eissn=1872-8006&rft.volume=1866&rft.issue=11&rft.spage=130215&rft_id=info:doi/10.1016%2Fj.bbagen.2022.130215&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon